Optimising quantitative 90Y PET imaging: an investigation into the effects of scan length and Bayesian penalised likelihood reconstruction

Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. J Vasc Interv Radiol. 2006;17(9):1425–39.

Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med. 2010;51(8):1206–12.

Leung TWT, Lau WY, Ho SKW, Ward SC, Chow JHS, Chan MSY, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33(4):919–24.

Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with Yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31(5):431–8.

Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18(4):553–61.

Gates VL, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, Nemcek AA, et al. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors. Future Oncol. 2007;3:73–81.

Dezarn WA, Cessna JT, Dewerd LA, Feng W, Gates VL, Halama J, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys. 2011;38(8):4824–45.

Garin E, Rolland Y, Laffont S, Edeline J. Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with90Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 2016;43(3):559–75.

Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53(2):255–63.

Wondergem M, Smits MLJ, Elschot M, de Jong HWAM, Verkooijen HM, van den Bosch MAAJ, et al. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med. 2013;54(8):1294–301.

Jiang M, Fischman A, Nowakowski FS. Segmental perfusion differences on paired Tc-99m macroaggregated albumin (MAA) hepatic perfusion imaging and Yttrium-90 (Y-90) bremsstrahlung imaging studies in SIR-sphere radioembolization: associations with angiography. J Nucl Med Radiat Ther. 2012;03(01):1–5.

D’Arienzo M. Emission of β+ particles via internal pair production in the 0+ − 0+ transition of 90Zr: historical background and current applications in nuclear medicine imaging. Atoms. 2013;1(1):2–12.

Wright CL, Zhang J, Tweedle MF, Knopp MV, Hall NC. Theranostic imaging of Yttrium-90. Biomed Res Int. 2015;2015:1–11.

Kao Y-H, Steinberg JD, Tay Y-S, Lim GK, Yan J, Townsend DW, et al. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. EJNMMI Res. 2013;3(1):56.

Willowson KP, Tapner M, Bailey DL, Bailey DL. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres. Eur J Nucl Med Mol Imaging. 2015;42(8):1202–22.

Miller TR, Wallis JW. Clinically important characteristics of maximum-likelihood reconstruction. J Nucl Med. 1992;33(9):1678–84.

Teoh EJ, McGowan DR, Macpherson RE, Bradley KM, Gleeson FV. Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system. J Nucl Med. 2015;56(9):1447–52.

Teoh EJ, McGowan DR, Bradley KM, Belcher E, Black E, Gleeson FV. Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules. Eur Radiol. 2016;26(2):576–84.

Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases? Eur J Radiol. 2015;84(10):1873–8.

Chilcott AK, Bradley KM, McGowan DR. Effect of a Bayesian penalized likelihood PET reconstruction compared with ordered subset expectation maximization on clinical image quality over a wide range of patient weights. Am J Roentgenol. 2018.

Rowley LM, Bradley KM, Boardman P, Hallam A, McGowan DR. Optimization of image reconstruction for 90 Y selective internal radiotherapy on a lutetium yttrium Orthosilicate PET/CT system using a Bayesian penalized likelihood reconstruction algorithm. J Nucl Med. 2017;58(4):658–64.

Goedicke A, Berker Y, Verburg FA, Behrendt FF, Winz O, Mottaghy FM. Study-parameter impact in quantitative 90-yttrium PET imaging for radioembolization treatment monitoring and dosimetry. IEEE Trans Med Imaging. 2013;32(3):485–92.

European Parliament. Council directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom a. Off J Eur Commun L13. 2014;1–73.